News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Heinrich Röder of Biodesix, Inc. to Present at 2013 Biomarker Summit


3/18/2013 6:25:49 AM

Biodesix, Inc., a fully integrated molecular diagnostics company dedicated to personalizing medicine, today announced that Chief Technology Officer Heinrich Röder, DPhil, will present at the 6th Oncology Biomarkers Conference as part of the Biomarker Summit 2013, being held March 20-22 in San Francisco. Dr. Röder will discuss how Biodesix’ high-throughput mass spectrometry technology, Deep MALDI™, is used to generate protein signatures for specific questions in oncology.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES